10x Genomics reports Q2 EPS 28c vs (32c) last year

Reports Q2 revenue $172.9M, consensus $139.51M. “The second quarter unfolded largely as anticipated,” said Serge Saxonov, Co-founder and CEO of 10x Genomics (TXG). “Amid continued uncertainty in the funding environment, we’re encouraged by the resilience of our business and the dedication of our team. We’re focused on disciplined execution, and remain confident in the strength of our technology, the momentum behind our platforms and the significant long-term opportunity in front of us.”